Is Belite Bio, Inc (BLTE) a Buy, Sell, or Hold?
NASDAQ : BLTE
Belite Bio, Inc — Competitors
$157.48 USD
$0.21 (0.13%)
- Volume
- 53.49K
- Average Volume
- 189.11K
- Market Capitalization
- $6.31B
- P/E Ratio
- -61.76
- Dividend Yield
- 0.00%
- Price Target
- $216.00
- Year High
- $200.00
- Year Low
- $60.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $33.71
BLTE vs. The Competition
| Properties | BLTE | ACAD | ADMA | ARQT |
|---|---|---|---|---|
| Market Cap | $6.31B | $4.94B | $2.13B | $3.35B |
| Shares Outstanding | $40.09M | $171.24M | $231.77M | $125.08M |
| P/E Ratio | -61.76 | 12.83 | 13.34 | -1393.25 |
| EPS | -2.26 | 2.22 | 0.7 | -0.02 |
| Day Low | 156.13 | 27.8 | 8.94 | 26.06 |
| Day High | 159.74 | 29.13 | 9.26 | 27.05 |
| Year Low | 60 | 19.69 | 7.21 | 13.695 |
| Year High | 200 | 29.13 | 20.458 | 31.77 |
| Average Price 50 | 148.0957 | 23.728 | 8.495 | 25.4526 |
| Average Price 200 | 150.43857 | 23.6605 | 13.31243 | 25.33395 |
| Volume | 53485.95 | 3.23M | 1.4M | 891.03K |
| Average Volume | - | - | - | - |